227586 - Pharmaceutical Price Regulation Scheme (Answered)

John Glen
To ask the Secretary of State for Health, what his most recent estimate is of the rebate which will be paid to the Exchequer in 2015-16 through the Pharmaceutical Price Regulation Scheme; what assessment he has made of the potential effect of greater use of unlicensed medicines for age-related macular degeneration on that rebate; and if he will make a statement.

George Freeman

The current Pharmaceutical Price Regulation Scheme (PPRS) payment estimate for the United Kingdom in 2015-16 is £995 million, as set out the note that accompanied my Written Statement HCWS90 of 11 December 2014, which is available at:

www.parliament.uk/business/publications/written-questions-answers-statements/written-statement/Commons/2014-12-11/HCWS90/

We have made no assessment of any effect that the use of unlicensed medicines for age-related macular degeneration might have on the level of PPRS payments.